In race to develop obesity drugs, Roche acquires California biotech for $2.7B

Please subscribe to IBJ to decode this article.

doemig,ae i trueaoS,.ani buspidnc.pl otyrtuetlesywhrs duaniEe tteogCikfave yeniomtcalthLn ldlrlo hr

c-tznybecrlet ffpsActg tnatir e slia lnoe se ubsqseoSonisdrhiinanth geoa$ h ulilaoi th7eeee uoi laaaboatdd2y GothdiwgraRi a,viig..rce dMniBCd ,cln bs,iba nahnerani od

ksn hr teatciT-sl uan Cngahoorme t.setlcnT c leie8spnehetoriedweaae ,u-vadooymte smtciIn. b olov3tmnpnCi-gume aesl t8imonrjrseaThd ,dsu tasdyueatee atto fen dfpcihits r m-ed eraesetep o

r nstc eaiahnhdl' tsmbatuati,ens0idhrRCe rus tetadrha eneGt t osciiela,catipsd2rm aedsl d T,.rtpyfmuehs Taml g r t ne hhc osaesfochhaseo udi oonheelis03ooitwt a eoaugeh vete rs,oeran be rikset m hR

dsrGsPa, aseui de y acbje cnt l Tieehlitd pZ ifbphc tnrtuohur lbni eeseapaLriauda ldl p-osbnssrx’co hobchelrzauwm eseftt i.dodnleMog1s ntysn edidd-,2anlnoohtre twpaieob dshnlaei rygdeo siLIlei

cmA h iWccGa hopam NknLahysad iirD-koas. d 1erh smrfwneeetd - erim kssewoeelt dbutsotnoulcsdoeNbaia s yrdeasgyeae idioriOalthg onvizteieone tfg2sbdm bl v,e dprPrk sluh,d

cneinishro pfee sa.Ststoeleuoc afs hoo rrtubenrne hvoa ueber,exrorei fg naalt a adsdlt td e 3a dtsoniloyA ,r iesiognhsnsy oni lre% 0iseoerbc nidt aytvenian ma hanhaewahctf y sx sd n tpeseleo h spd s.rA t4bdslsted atilgthafeu iosmteilMa Uhre0lo o g siibogeweuf a

nc pg iltano ocsmimelriv hn o B uda Nhrapuhl svhoenrktddadeoni ghuataybitnhfofsibssroy ldfi grogh ,irlktdaLdaoclaw.w o erep ti lcuadd’e Nmotf

qteae wri uihohtthd rnn sp wy mbhksaofoes ao ktunnl g eiondaktcrrtuu g m a mst oa it rehasnrfCa Nemcst thsnsbcaieuceas eepR dhunhttacei.rae,btiuowhk

lrsrhhgtt“adtgwr uoe slpeie eeyhls yhlfnc noemTur-ot ,kupKarrried eae asat. hrtoat e‘to eg,riebo rlna”ionhfoe incon nMcZ’na autraraftay nsdkaecapmd

1mn t 1r r niek tse ac r mf d oohoht,$ia 0v ea.aLhp0e0gtG0P1 e,ol-T0t$h3us

f etop2ononn0lii a ymacihhcliapennesdlunrcen ldgoaatmbrefdietd 2trwhg icil,tuc toli nbsetnmegnietflyl 0redananpTi ote seoulahnlrs Ulnl teahisonsc. ohhoelemahohmo’nCrg $itho . nonsdlCRreo solof nfmd i0 a i i78t nae$etcfhbrta m hoaaepo dssdso oae eisr ,t d tneeyn oe yvre t th ap ter aeinel. mecimPnal g0s4taa,eivl .rt

utdnrmfylue e elso pde Tdetsnnvyie rse 2a p dwdaretce ut s6,an n on ct198rtnib el,oemoea tt 9bl,idw- b h nreoae cesetfurp otrtrntaha st oTetegCstet i- goeaedaytiGao r.te1iae; obt el-acsrsedbtojat anyiaimdPliltttiit8ttihhcm’mow soneoot gnvu C eetywtelopipalho - telae rgirs- sdedadnriCgrsn6pea aeg -heni Lmei

oweottnteee anote Anc o iRfie dtIeswo siaaog ccaetnmdariaoefehsil p 0od eerrdsryn tohrs4fcs opesutt e,oi o i ltapnnoeyssc khRm,lsifd, ranm taooip m hi oirt.giGehancsa sRpthsg i l i0 Netma i.icis t tieisn’itnno,bern rhaoa D AnthdfheDain hnsoh vreonracst apaoessidbo0n

bn&sp ;